Hepatitis B and C Therapies

12.09.2010

You are here

Prof. Yair Reisner
 
Prof. Yair Reisner developed mice with functioning human immune systems. These laboratory animals can be used for research on a broad range of human diseases.
 

Application

 
XTL Biopharmaceuticals Ltd. in Rehovot was set up to make use of Reisner’s technology. The company currently develops therapies for hepatitis B and C with the help of the mice. It is also developing drugs to treat other infectious diseases based on human antibodies.
 

Share